speakers
The ChinaBio® Investor Forum features speakers from the US and China that are renowned experts in their fields, including:
- The State of the China Biotech Industry - China's biotech and life science industry is rapidly becoming a global force. And it is the fastest growing industry segment in VC investment.
- Attacting Capital - Learn what US and China investors are looking for in early and mid-stage biotechnology, pharmaceutical and life science companies, and what types of companies are bringing in funding.
- Global Corporate Structure - How to set up a global biotech in China using US, BVI, Cayman, WFOE, holding companies, subsidiaries, etc.
- International Intellectual Property - How to create a patent portfolio that will protect your intellectual property globally.
- Outsourcing - How to reduce your costs and improve the return on investment by using CROs and CMOs to perform much of the work in drug development.
Speaker List
The following industry experts will be providing insights into China's emerging biotechnology industry and how to launch and build a successful life science companies at the ChinaBio® Investor Forum. (Click here for Speaker Bios.)
Keynote Speakers:
George Chen, PhD - Area VP, GlaxoSmithKline (GSK) China/HK Medical and Clinical Research
Daxu Fu, PhD - CTO, Shanghai Centre of Research & Development of New Drugs
Shouchun Zhu (朱守淳) - Vice General Manager, Zhangjiang Group, Zhangjiang Hi-Tech Park
Speakers and Panelists:
Charles Hsu, PhD, MBA - Partner, Bay City Capital; Co-founder, LEAD Therapeutics
Jason (Gang) Jin, PhD - President/CEO, MaxyBio Corporation; SVP Shanghai BioChip Co. Ltd.
Kevin Li, PhD - Partner, HBM BioMed China
Yuwen Liu - Vice President, Suzhou Industrial Park / BioBay / Suzhou Venture Group
Dongxu Qiu, PhD, MBA - President and Founder, BioOperations Consulting, Inc.
Greg B. Scott – President and founder, ChinaBio™ Accelerator
Aron Stern - CFO, Vital Therapies, Inc.
Zhaohui (Zoe) Wang, PhD, JD - Partner, Perkins Coie LLP
Michael Warnecke, JD - Partner, Perkins Coie LLP
Don Williams, JD - Partner, Wilson Sonsini Goodrich & Rosati
David Xu, PhD - Managing Partner, Mingly China Growth Fund
Fan Zhang, MBA - Founding Managing Partner, Sequoia Capital
Qiang (Sean) Zhang, PhD - Principal, BioVeda, China
Kan Zu - Partner, Unitalen Attorneys at Law
Presenting Companies
The following companies will be presenting at the ChinaBio® Investor Forum on Wednesday, Dec. 5:
|
Company / Speaker
|
Description
|
ABMax (Beijing)
Le Sun, PhD, CEO |
Custom monoclonal antibody services |
ACCB Biotech (Beijing)
Xu Junpu, MBA, CEO |
Molecular diagnostics and personalized therapy for cancer |
AQChem (Shanghai)
Jack Lu, PhD, CEO |
Drug discovery chemical products and services |
AutekBio (Beijing)
Julius Li, MBA, CEO |
Contract manufacturing of biologic products |
ChinaBio Therapeutics (SH)
Greg Scott, CEO |
Drug development leveraging China's low cost/high quality infrstructure |
Chiral Quest, Inc. (Jiashan)
Xumu Zhang, PhD, CTO |
Contract manufacturing of chiral drug candidates |
Crown Bioscience, Inc. (Beijing)
William Pan, PhD, President |
In vivo pharmacology and monoclonal antibody services |
Fountain Medical Dev. (Tianjin)
Dan Zhang, PhD, CEO |
Contract clinical trial management services |
GenePharma (Suzhou)
Peter Zhang, PhD, CEO |
siRNA products and chemical synthesis services |
Generon Corporation (Shanghai)
Yu Liang Huang, PhD, CEO |
Drug development for obesity |
LEAD Therapeutics (Shanghai)
Charles Hsu, PhD, CEO |
Chemistry-driven small molecule drug discovery company |
MicuRX Pharmaceutical (SH)
Zhengyu Yuan, PhD, CEO |
Development of anti-infective medicines |
Mgene, Inc. (Shanghai)
Ahmed Bouzidi, PhD, CEO |
Development of drugs for malaria, Hep-C and HIV |
PanAsia Bio (Shanghai)
Michael Xu, PhD, President |
Pegylation technology and PEG-based drug development |
Shanghai BioChip (Shanghai)
Jason Jin, PhD, EVP |
Biological drug discovery services with GLP, GCP and GMP labs |
Sirnaomics, Inc. (US/China)
Patrick Lu, PhD, CEO |
Drug development based on siRNA technologies |
|
|